If you are unsure what to do, contact your clinical team before taking any action
The Bottom Line The appeal of needle-free GLP-1 options is understandable, but the current evidence does not support sublingual semaglutide drops or weight loss patches as effective alternatives to proven treatments
This post examines why the approval matters, how small-molecule GLP-1 agonists compare with peptides, and what the shift means for patent strategy and the pipeline ahead
Theres no probing to see if you understood anything. Cella, with the American Telemedicine Association, said the group has not addressed the difficulty of educating patients about the risks of injecting weight loss drugs
Brief exposure (under 30 minutes) to moderate heat (86-100 degrees) typically does not cause significant degradation for most GLP-1 formulations
Some for medical necessity, others for self-improvement